Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients.

Jia, Bin; Xia, Peiyi; Dong, Junqiang; Feng, Wenhao; Wang, Wenjia; Liu, Enjie; Jiang, Guozhong; Qin, Yanru

Jia, Bin; Xia, Peiyi; Dong, Junqiang; Feng, Wenhao; Wang, Wenjia; Liu, Enjie; Jiang, Guozhong; Qin, Yanru.

Afiliação

Jia B; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xia P; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Dong J; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Feng W; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wang W; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Liu E; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jiang G; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Qin Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Front Oncol ; 12: 1086908, 2022.

Article em En | MEDLINE | ID: mdl-36741696

Palavras-chave

gene mutation; genetic testing; hepatic tumors; prognosis; sarcomatoid carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google